Titre : Acrylamide

Acrylamide : Questions médicales fréquentes

Termes MeSH sélectionnés :

Decision Making
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acrylamide : Questions médicales les plus fréquentes", "headline": "Acrylamide : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acrylamide : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acrylamide" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acrylamides", "url": "https://questionsmedicales.fr/mesh/D000178", "about": { "@type": "MedicalCondition", "name": "Acrylamides", "code": { "@type": "MedicalCode", "code": "D000178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.081.069.094" } } }, "about": { "@type": "MedicalCondition", "name": "Acrylamide", "alternateName": "Acrylamide", "code": { "@type": "MedicalCode", "code": "D020106", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fang Chen", "url": "https://questionsmedicales.fr/author/Fang%20Chen", "affiliation": { "@type": "Organization", "name": "College of Food Science and Nutritional Engineering, National Engineering Research Center for Fruit and Vegetable Processing, Key Laboratory of Fruits and Vegetables Processing, Ministry of Agriculture, Engineering Research Centre for Fruits and Vegetables Processing, Ministry of Education, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, Beijing 100083, China. Electronic address: chenfangch@sina.com." } }, { "@type": "Person", "name": "Katarzyna Petka", "url": "https://questionsmedicales.fr/author/Katarzyna%20Petka", "affiliation": { "@type": "Organization", "name": "Department of Plant Products Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Kraków, Poland." } }, { "@type": "Person", "name": "Aleksandra Duda-Chodak", "url": "https://questionsmedicales.fr/author/Aleksandra%20Duda-Chodak", "affiliation": { "@type": "Organization", "name": "Department of Fermentation Technology and Microbiology, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Kraków, Poland." } }, { "@type": "Person", "name": "Milena Bušová", "url": "https://questionsmedicales.fr/author/Milena%20Bu%C5%A1ov%C3%A1", "affiliation": { "@type": "Organization", "name": "Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic." } }, { "@type": "Person", "name": "Vladimír Bencko", "url": "https://questionsmedicales.fr/author/Vladim%C3%ADr%20Bencko", "affiliation": { "@type": "Organization", "name": "Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Epistemic justice is the basis of shared decision making.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36871402", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pec.2023.107681" } }, { "@type": "ScholarlyArticle", "name": "Cardiac cycle affects risky decision-making.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36464201", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopsycho.2022.108471" } }, { "@type": "ScholarlyArticle", "name": "Default beliefs as a basis of social decision-making.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36243672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tics.2022.09.004" } }, { "@type": "ScholarlyArticle", "name": "Clinical decision making of post-treatment disease.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35905008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/iej.13806" } }, { "@type": "ScholarlyArticle", "name": "Tools for Contralateral Prophylactic Mastectomy Decision Making.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35759730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1200/JCO.21.02782" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Acides acycliques", "item": "https://questionsmedicales.fr/mesh/D000144" }, { "@type": "ListItem", "position": 5, "name": "Acrylates", "item": "https://questionsmedicales.fr/mesh/D000179" }, { "@type": "ListItem", "position": 6, "name": "Acrylamides", "item": "https://questionsmedicales.fr/mesh/D000178" }, { "@type": "ListItem", "position": 7, "name": "Acrylamide", "item": "https://questionsmedicales.fr/mesh/D020106" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acrylamide - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acrylamide", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acrylamide", "description": "Comment détecte-t-on l'exposition à l'acrylamide ?\nQuels tests sont utilisés pour évaluer les effets de l'acrylamide ?\nY a-t-il des symptômes spécifiques à l'intoxication par l'acrylamide ?\nComment évaluer les risques liés à l'acrylamide ?\nQuels professionnels peuvent diagnostiquer l'exposition à l'acrylamide ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acrylamide", "description": "Quels sont les symptômes d'une exposition aiguë à l'acrylamide ?\nL'acrylamide cause-t-il des effets à long terme ?\nY a-t-il des signes de toxicité chronique ?\nLes symptômes varient-ils selon l'exposition ?\nL'acrylamide affecte-t-il le système nerveux ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acrylamide", "description": "Comment réduire l'exposition à l'acrylamide dans l'alimentation ?\nQuels aliments contiennent le plus d'acrylamide ?\nLes réglementations alimentaires limitent-elles l'acrylamide ?\nLes entreprises alimentaires doivent-elles surveiller l'acrylamide ?\nY a-t-il des recommandations pour les consommateurs ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acrylamide", "description": "Quel traitement existe pour l'intoxication par l'acrylamide ?\nComment gérer les symptômes neurologiques liés à l'acrylamide ?\nDes antidotes existent-ils pour l'acrylamide ?\nLes patients doivent-ils être hospitalisés ?\nQuels spécialistes peuvent traiter les effets de l'acrylamide ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acrylamide", "description": "Quelles sont les complications possibles de l'exposition à l'acrylamide ?\nL'acrylamide peut-il causer des cancers ?\nY a-t-il des effets sur la reproduction liés à l'acrylamide ?\nLes effets de l'acrylamide sont-ils réversibles ?\nComment surveiller les complications liées à l'acrylamide ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acrylamide", "description": "Qui est le plus à risque d'exposition à l'acrylamide ?\nLes fumeurs sont-ils plus exposés à l'acrylamide ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des prédispositions génétiques à l'acrylamide ?\nLes habitudes alimentaires influencent-elles le risque d'acrylamide ?", "url": "https://questionsmedicales.fr/mesh/D020106?mesh_terms=Decision+Making&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on l'exposition à l'acrylamide ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition peut être évaluée par des tests biologiques mesurant l'acrylamide dans l'urine." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les effets de l'acrylamide ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires peuvent évaluer les niveaux d'acrylamide et ses métabolites." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à l'intoxication par l'acrylamide ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des troubles neurologiques, mais ils ne sont pas spécifiques." } }, { "@type": "Question", "name": "Comment évaluer les risques liés à l'acrylamide ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation des risques se fait par des études épidémiologiques et des analyses toxicologiques." } }, { "@type": "Question", "name": "Quels professionnels peuvent diagnostiquer l'exposition à l'acrylamide ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins spécialisés en médecine du travail et en toxicologie peuvent diagnostiquer l'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë à l'acrylamide ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des maux de tête, des nausées et des troubles neurologiques." } }, { "@type": "Question", "name": "L'acrylamide cause-t-il des effets à long terme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des neuropathies et des effets cancérogènes." } }, { "@type": "Question", "name": "Y a-t-il des signes de toxicité chronique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité chronique incluent des troubles moteurs et des problèmes cognitifs." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'exposition ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent de la durée et du niveau d'exposition à l'acrylamide." } }, { "@type": "Question", "name": "L'acrylamide affecte-t-il le système nerveux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'acrylamide peut causer des dommages au système nerveux central et périphérique." } }, { "@type": "Question", "name": "Comment réduire l'exposition à l'acrylamide dans l'alimentation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de cuire les aliments à haute température et privilégiez les méthodes de cuisson douces." } }, { "@type": "Question", "name": "Quels aliments contiennent le plus d'acrylamide ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les aliments frits, grillés ou cuits au four, comme les pommes de terre, contiennent souvent de l'acrylamide." } }, { "@type": "Question", "name": "Les réglementations alimentaires limitent-elles l'acrylamide ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs pays ont mis en place des réglementations pour limiter l'acrylamide dans les aliments." } }, { "@type": "Question", "name": "Les entreprises alimentaires doivent-elles surveiller l'acrylamide ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les entreprises doivent surveiller et réduire les niveaux d'acrylamide dans leurs produits." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les consommateurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les consommateurs sont conseillés de diversifier leur alimentation et de limiter les aliments frits." } }, { "@type": "Question", "name": "Quel traitement existe pour l'intoxication par l'acrylamide ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique, mais des soins symptomatiques peuvent être fournis." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques liés à l'acrylamide ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La gestion peut inclure des thérapies physiques et des médicaments pour soulager les symptômes." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour l'acrylamide ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour l'acrylamide, le traitement est symptomatique." } }, { "@type": "Question", "name": "Les patients doivent-ils être hospitalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation dépend de la gravité des symptômes et de l'exposition à l'acrylamide." } }, { "@type": "Question", "name": "Quels spécialistes peuvent traiter les effets de l'acrylamide ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les neurologues et les toxicologues sont souvent impliqués dans le traitement des effets de l'acrylamide." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'exposition à l'acrylamide ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des cancers et des problèmes de reproduction." } }, { "@type": "Question", "name": "L'acrylamide peut-il causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'acrylamide est classé comme cancérogène potentiel par certaines agences de santé." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction liés à l'acrylamide ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que l'acrylamide peut affecter la fertilité et le développement fœtal." } }, { "@type": "Question", "name": "Les effets de l'acrylamide sont-ils réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certains effets peuvent être réversibles, mais d'autres, comme les dommages nerveux, peuvent être permanents." } }, { "@type": "Question", "name": "Comment surveiller les complications liées à l'acrylamide ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance se fait par des examens médicaux réguliers et des évaluations neurologiques." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition à l'acrylamide ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus à risque d'exposition." } }, { "@type": "Question", "name": "Les fumeurs sont-ils plus exposés à l'acrylamide ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente l'exposition à l'acrylamide en raison de sa présence dans la fumée." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets de l'acrylamide en raison de la santé générale." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques à l'acrylamide ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variations génétiques peuvent influencer la métabolisation de l'acrylamide, augmentant le risque." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque d'acrylamide ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en aliments frits et grillés augmente le risque d'exposition à l'acrylamide." } } ] } ] }

Sources (10000 au total)

Epistemic justice is the basis of shared decision making.

There is little evidence that share decision-making (SDM) is being successfully implemented, with a significant gap between theory and clinical practice. In this article we look at SDM explicitly ackn... We propose to see conditions for shared decision-making in terms of epistemic justice, an explicit acknowledgment and acceptance of the legitimacy of healthcare users and their accounts and knowledges... The epistemic-justice perspective we adopt leads to at least three implications for clinical practices. First, clinical training must go beyond the development of communication skills and focus more o...

Tools for Contralateral Prophylactic Mastectomy Decision Making.

Women with unilateral breast cancer are increasingly opting for the removal of not only the involved breast, but also for the removal of the opposite uninvolved breast (contralateral prophylactic mast... We based our analyses on two published models for CBC and published information on the hazards of regional and distant recurrences and non-breast cancer mortality. Assuming that CPM eliminates CBC but... The risk of CBC and total risk vary greatly, depending on the breast cancer subtype. In some cases, a decision for or against CPM can be based on CBC risk alone, but in others, additional consideratio... There is a potential to develop more informative tools for deciding on CPM. Realizing this potential will require more and better data to validate existing models of absolute CBC risk and to character...

[Decision making in frail patients with a hip fracture].

When an older patient presents herself at the emergency department with a femur fracture different doctors are involved: the geriatrician, the orthopaedic or trauma- surgeon and the anaesthesiologist.... In this case description we present a patient with cardiovascular comorbidity and dementia. Mis-interpretation or missing information can lead to different treatment decisions and outcomes.... Effective cooperation and transfer of information in physical consultation is crucial in the care of frail patients....

Enhanced women's decision-making power after the

Women's decision-making power is a dimension of empowerment and is crucial for better physical and psychosocial outcomes of mothers.... The evaluation design was a cluster randomised pre-post design with two cross-sectional surveys conducted among beneficiary women with at least one child aged <23 months from randomly selected poor or... Decision-making indicators included food purchases, major household purchases, food preparation, children's healthcare as well as women's own healthcare and visiting family and relatives.... Our findings suggest that 45% of women were able to make decisions on food purchases, 25% on major household purchases, 78% on food preparation, 59% on children's healthcare, 51% on their own healthca... In terms of food purchases, major household purchases, children's healthcare, their own healthcare and visiting family and relatives, the... RIDIE-STUDY-ID-5d5678361809b....

Decision making for early surgical technology adoption into Canada's healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities.

In 2020, Canada spent 12.9 percent of its GDP on healthcare, of which 3 percent was on medical devices. Early adoption of innovative surgical devices is mostly driven by physicians and delaying adopti... This scoping review was guided by the Joanna Briggs Institute Manual for Evidence Synthesis and PRISMA-ScR reporting guidelines. The search strategy included Canada's provinces, different surgical fie... Overall, 155 studies were found. Seven were hospital-specific studies and 148 studies were from four provinces with publicly available Web sites for technology assessment committees (Alberta, British ... Specific criteria for decision making in the early adoption stage of novel surgical technologies are lacking. These criteria need to be identified, standardized, and applied in order to provide innova...